Medical and pharmaceutical innovation slows down in Europe, with a decline in patent applications submitted in 2024, a new ...

Bayer said on Wednesday it struck a global licence agreement for an experimental oral cancer drug for targeted therapies with ...

FDA reviews TNX-102 SL for Fibromyalgia by August 2025, with no advisory required. See why we recommend a buy on TNXP stock.

As we head into the home stretch of the 2025 legislative session, pressure mounts to protect patient care, hospitals and ...

Shares of West Pharmaceutical Services, Inc. (NYSE:WST – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the seven research firms that are covering the firm, Ratings ...

Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC ...

The data to be presented encompasses five of the company’s novel drug candidates: BCR-ABL tyrosine kinase inhibitor olverembatinib (HQP1351), Bcl-2 inhibitor lisaftoclax (APG-2575), FAK/ALK/ROS1 ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

Walgreen Co., Kroger Co., and Albertsons Cos. Inc. accused two pharmaceutical companies Tuesday of conspiring to delay the generic version of a drug to treat gastroesophageal reflux disease and ...

Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity ...

A looming patent cliff is driving Big Pharma reorganization. Executives making career moves must understand differences in ...